title: Is there a link between amyotrophic lateral sclerosis and treatment with TNF-alpha inhibitors?
authors.forename: A
authors.initials: A
authors.lastname: Börjesson
authors.forename: B
authors.initials: B
authors.lastname: Grundmark
authors.forename: H
authors.initials: H
authors.lastname: Olaisson
authors.forename: L
authors.initials: L
authors.lastname: Waldenlind
mesh_terms: D000068879:Adalimumab; D016907:Adverse Drug Reaction Reporting Systems; D000690:Amyotrophic Lateral Sclerosis / Q000209:etiology*; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000628:therapy; D062313:Databases, Pharmaceutical; D000068800:Etanercept; D005060:Europe; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects; D000069285:Infliximab; D060735:Pharmacovigilance; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab; D000068800:Etanercept
references.citation: Acta Neurobiol Exp (Wars). 2008;68(4):526-34
references.pmid: 19112477
references.citation: Cell Signal. 2010 Jul;22(7):977-83
references.pmid: 20096353
references.citation: J Neurosci. 2006 Jan 4;26(1):143-51
references.pmid: 16399681
references.citation: Rheumatol Int. 2011 Jun;31(6):715-9
references.pmid: 21258799
references.citation: J Neuroimmune Pharmacol. 2012 Mar;7(1):42-59
references.pmid: 21728035
references.citation: Brain. 1995 Jun;118 ( Pt 3):707-19
references.pmid: 7600088
references.citation: PLoS One. 2011;6(11):e27621
references.pmid: 22110694
references.citation: Joint Bone Spine. 2009 Mar;76(2):213-4
references.pmid: 18955008
references.citation: Drug Saf. 2006;29(5):385-96
references.pmid: 16689555
references.citation: Mod Rheumatol. 2008;18(3):228-39
references.pmid: 18437286
references.citation: J Neurochem. 2008 Nov;107(4):1158-67
references.pmid: 18823372
references.citation: Rheumatology (Oxford). 2008 Jul;47(7):1061-4
references.pmid: 18499716
references.citation: JAMA. 2002 Oct 2;288(13):1588
references.pmid: 12350188
references.citation: Rheumatology (Oxford). 2006 Nov;45(11):1445-6
references.pmid: 16877458
references.citation: J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):385-90
references.pmid: 19710046
references.citation: Ann Rheum Dis. 2010 Oct;69(10):1803-8
references.pmid: 20447953